Active, not recruitingPhase 2NCT04044768

Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

Studying Myxoid/round cell liposarcoma

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: USWM CT, LLC
Principal Investigator: Dejka Araujo, MD
MD Anderson Cancer Center; Houston TX 77030
Intervention: afamitresgene autoleucel (previously ADP-A2M4)(genetic)
Enrollment: 52 enrolled
Eligibility: 10-75 years · All sexes
Timeline: 2019 – 2038

Study locations (26)

City of Hope, Duarte, California, United States
Stanford Cancer Center, Palo Alto, California, United States
University of Colorado, Aurora, Colorado, United States
Mayo Clinic Jacksonville, Jacksonville, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
Northwestern University Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, United States
National Cancer Institute, Bethesda, Maryland, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
University of Michigan, Ann Arbor, Michigan, United States
Washington University School of Medicine, St Louis, Missouri, United States
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Ohio State University, Columbus, Ohio, United States
Vanderbilt, Nashville, Tennessee, United States
MD Anderson Cancer Center, Houston, Texas, United States
+11 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04044768 on ClinicalTrials.gov

Other trials for Myxoid/round cell liposarcoma

Additional recruiting or active studies for the same condition.

See all trials for Myxoid/round cell liposarcoma →

← Back to all trials